To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Topics and Featured Experts:
Omicron Update
Lauri Hicks, DO
Chief Medical Officer
CDC COVID-19 Response
U.S. Centers for Disease Control and Prevention
Updates from FDA
John Farley, MD, MPH
Director of the Office of Infectious Diseases
U.S. Food and Drug Administration
Updates from ASPR
Colin W. Shepard, MD
CDC Liaison to the HHS Assistant Secretary for Preparedness & Response (ASPR)
U.S. Centers for Disease Control and Prevention
Clinical Recommendations & Considerations
Rajesh Gandhi, MD, FIDSA
Director, HIV Clinical Services and Education
Massachusetts General Hospital
Co-Director, Harvard Center for AIDS Research
Professor of Medicine, Harvard Medical School
Kathryn M. Edwards, MD
Sarah H. Sell and Cornelius Vanderbilt Professor
Division of Infectious Diseases
Department of Pediatrics
Vanderbilt University Medical Center
Lindsey R. Baden, MD
Professor of Medicine, Harvard Medical School
Director of Clinical Research, Division of Infectious Diseases
Brigham and Women's Hospital
Director, Infectious Diseases, Dana-Farber Cancer Institute
Amy Hirsch Shumaker, PharmD, BCPS
Clinical Specialist, Infectious Disease
VA Northeast Ohio Healthcare System
Senior Clinical Instructor
Case Western Reserve University, School of Medicine
Jason Gatliff, PhD
Integrated Ethics Program Officer
VA Northeast Ohio Healthcare System
